Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 3 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 10, 2020 Filed Jan 14, 2020 22:16 UTC |
David GlennChief Financial Officer
|
GrantPhantom Stock Unit · Derivative | 219.6904 | $42.28 | $9,288.51 |
DisclosureSEC source: 0001555280-20-000020 · wf-form4_157904018200898.xml · derivative · entry 1 David Glenn · CIK 0001606256 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,616.7575 Underlying: Common Stock · 68.5145 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 22:08 UTC |
Chen Heidi C.Executive Vice President
|
GrantPhantom Stock Unit · Derivative | 195.8113 | $42.28 | $8,278.90 |
DisclosureSEC source: 0001555280-20-000016 · wf-form4_157903972102672.xml · derivative · entry 1 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,555.1125 Underlying: Common Stock · 61.0673 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 21:54 UTC |
Kelly Robert EdwardExecutive Vice President
|
GrantPhantom Stock Unit · Derivative | 138.0232 | $42.28 | $5,835.62 |
DisclosureSEC source: 0001555280-20-000012 · wf-form4_157903883124524.xml · derivative · entry 1 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,998.3748 Underlying: Common Stock · 43.0451 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 21:38 UTC |
Lagano RoxanneExecutive Vice President
|
GrantPhantom Stock Unit · Derivative | 178.2997 | $42.28 | $7,538.51 |
DisclosureSEC source: 0001555280-20-000008 · wf-form4_157903789139170.xml · derivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,024.4322 Underlying: Common Stock · 55.606 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 22:02 UTC |
Alaix Juan RamonDirector
|
GrantPhantom Stock Unit · Derivative | 382.0695 | $42.28 | $16,153.90 |
DisclosureSEC source: 0001555280-20-000015 · wf-form4_157903930749846.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,275.2678 Underlying: Common Stock · 119.1554 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 21:50 UTC |
Nayak Abhay USenior Vice President
|
GrantPhantom Stock Unit · Derivative | 70.7524 | $42.28 | $2,991.41 |
DisclosureSEC source: 0001555280-20-000010 · wf-form4_157903856345262.xml · derivative · entry 1 Nayak Abhay U · CIK 0001797754 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70.7524 Underlying: Common Stock · 22.0654 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 16:54 UTC |
STEERE WILLIAM C JRDirector
|
GrantPhantom Stock Unit · Derivative | 197.691 | $126.46 | $25,000.00 |
DisclosureSEC source: 0001555280-19-000307 · wf-form4_157670607393606.xml · derivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,562.9797 Underlying: Common Stock · 197.691 shares Expires not disclosed F1 · security: These phantom stock units were acquired pursuant to the Zoetis Non-Employee Director Deferred Compensation Plan and represent the director's deferral of all or a portion of his or her cash retainer fees invested in the Zoetis stock fund (including dividend equivalents thereon). F2 · derivative.exercise_price: Each phantom stock unit represents one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: These phantom stock units will be settled in cash following the reporting person's separation from service. F3 · derivative.expiration_date: These phantom stock units will be settled in cash following the reporting person's separation from service. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 21:49 UTC |
SCULLY ROBERT WDirector
|
GrantPhantom Stock Unit · Derivative | 247.1137 | $126.46 | $31,250.00 |
DisclosureSEC source: 0001555280-19-000305 · wf-form4_157670578039490.xml · derivative · entry 1 SCULLY ROBERT W · CIK 0001352881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,093.9757 Underlying: Common Stock · 247.1137 shares Expires not disclosed F1 · security: These phantom stock units were acquired pursuant to the Zoetis Non-Employee Director Deferred Compensation Plan and represent the director's deferral of all or a portion of his or her cash retainer fees invested in the Zoetis stock fund (including dividend equivalents thereon). F2 · derivative.exercise_price: Each phantom stock unit represents one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: These phantom stock units will be settled in cash following the reporting person's separation from service. F3 · derivative.expiration_date: These phantom stock units will be settled in cash following the reporting person's separation from service. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 21:34 UTC |
Lewis Clinton A. Jr.Executive Vice President
|
Exercise / conversionStock Option · Derivative | 3,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000303 · wf-form4_157670479075126.xml · derivative · entry 3 Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,062 Underlying: Common Stock · 3,566 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. Each option vests on the third anniversary of the date of grant. F4 · derivative.exercise_price: 3,566 options granted January 31, 2013 at an exercise price of $26.00 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 46,816 options granted March 4, 2014 at an exercise price of $30.89 per option; 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option; 35,746 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; and 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 21:34 UTC |
Lewis Clinton A. Jr.Executive Vice President
|
SaleCommon Stock | 6,123 | $124.93 | $764,946.39 |
DisclosureSEC source: 0001555280-19-000303 · wf-form4_157670479075126.xml · nonDerivative · entry 2 Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,904 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.50 to $125.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 21:34 UTC |
Lewis Clinton A. Jr.Executive Vice President
|
Exercise / conversionCommon Stock | 3,566 | $26.00 | $92,716.00 |
DisclosureSEC source: 0001555280-19-000303 · wf-form4_157670479075126.xml · nonDerivative · entry 1 Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2018. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 16:34 UTC |
Fenton AndrewExecutive Vice President
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,044.8296 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-19-000292 · wf-form4_157601363682143.xml · derivative · entry 3 Fenton Andrew · CIK 0001538226 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,437.6359 Underlying: Common Stock · 3,044.8296 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,044.8296 RSUs vested on December 6, 2019; 4,315.1404 RSUs will vest on February 14, 2020; 3,679.2908 RSUs will vest on February 13, 2021; and 3,443.2047 RSUs will vest on February 12, 2022. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F2 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,044.8296 RSUs vested on December 6, 2019; 4,315.1404 RSUs will vest on February 14, 2020; 3,679.2908 RSUs will vest on February 13, 2021; and 3,443.2047 RSUs will vest on February 12, 2022. F2 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,044.8296 RSUs vested on December 6, 2019; 4,315.1404 RSUs will vest on February 14, 2020; 3,679.2908 RSUs will vest on February 13, 2021; and 3,443.2047 RSUs will vest on February 12, 2022. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 16:34 UTC |
Fenton AndrewExecutive Vice President
|
Tax withholdingCommon Stock | 1,501 | $121.72 | $182,701.72 |
DisclosureSEC source: 0001555280-19-000292 · wf-form4_157601363682143.xml · nonDerivative · entry 2 Fenton Andrew · CIK 0001538226 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,073 Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 16:34 UTC |
Fenton AndrewExecutive Vice President
|
Exercise / conversionCommon Stock | 3,044 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-19-000292 · wf-form4_157601363682143.xml · nonDerivative · entry 1 Fenton Andrew · CIK 0001538226 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,574 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 21:50 UTC |
David GlennChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,044.8296 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-19-000294 · wf-form4_157601461564253.xml · derivative · entry 3 David Glenn · CIK 0001606256 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,160.1338 Underlying: Common Stock · 3,044.8296 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,044.8296 RSUs vested on December 6, 2019; 8,631.2987 RSUs will vest on February 14, 2020; 7,359.5927 RSUs will vest on February 13, 2021; and 6,169.2424 RSUs will vest on February 12, 2022. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F2 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,044.8296 RSUs vested on December 6, 2019; 8,631.2987 RSUs will vest on February 14, 2020; 7,359.5927 RSUs will vest on February 13, 2021; and 6,169.2424 RSUs will vest on February 12, 2022. F2 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,044.8296 RSUs vested on December 6, 2019; 8,631.2987 RSUs will vest on February 14, 2020; 7,359.5927 RSUs will vest on February 13, 2021; and 6,169.2424 RSUs will vest on February 12, 2022. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 21:50 UTC |
David GlennChief Financial Officer
|
Tax withholdingCommon Stock | 1,501 | $121.72 | $182,701.72 |
DisclosureSEC source: 0001555280-19-000294 · wf-form4_157601461564253.xml · nonDerivative · entry 2 David Glenn · CIK 0001606256 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,831 Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 21:50 UTC |
David GlennChief Financial Officer
|
Exercise / conversionCommon Stock | 3,044 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-19-000294 · wf-form4_157601461564253.xml · nonDerivative · entry 1 David Glenn · CIK 0001606256 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| December 03, 2019 Filed Dec 4, 2019 21:31 UTC |
David GlennChief Financial Officer
|
Exercise / conversionStock Option · Derivative | 16,861 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000288 · wf-form4_157549504654554.xml · derivative · entry 6 David Glenn · CIK 0001606256 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,453 Underlying: Common Stock · 16,861 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F8 · derivative.exercise_price: 16,861 options granted August 22, 2016 at an exercise price of $51.23 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F9 · balance_after: 7,712 options granted February 27, 2015 at an exercise price of $46.09 per option; 11,144 options granted December 6, 2016 at an exercise price of $50.22 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 26,285 options granted February 13, 2018 at an exercise price of $73.24 per option; and 24,678 options granted February 12, 2019 at an exercise price of $87.51 per option. Read SEC document |
| December 03, 2019 Filed Dec 4, 2019 21:31 UTC |
David GlennChief Financial Officer
|
SaleCommon Stock | 16,861 | $120.17 | $2,026,186.37 |
DisclosureSEC source: 0001555280-19-000288 · wf-form4_157549504654554.xml · nonDerivative · entry 4 David Glenn · CIK 0001606256 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,288 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.07 to $120.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 03, 2019 Filed Dec 4, 2019 21:31 UTC |
David GlennChief Financial Officer
|
Exercise / conversionCommon Stock | 16,861 | $51.23 | $863,789.03 |
DisclosureSEC source: 0001555280-19-000288 · wf-form4_157549504654554.xml · nonDerivative · entry 3 David Glenn · CIK 0001606256 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 21:31 UTC |
David GlennChief Financial Officer
|
Exercise / conversionStock Option · Derivative | 4,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000288 · wf-form4_157549504654554.xml · derivative · entry 5 David Glenn · CIK 0001606256 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,314 Underlying: Common Stock · 4,440 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 4,440 options granted August 22, 2016 at an exercise price of $51.23 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 7,712 options granted February 27, 2015 at an exercise price of $46.09 per option; 16,861 options granted August 22, 2016 at an exercise price of $51.23 per option; 11,144 options granted December 6, 2016 at an exercise price of $50.22 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 26,285 options granted February 13, 2018 at an exercise price of $73.24 per option; and 24,678 options granted February 12, 2019 at an exercise price of $87.51 per option. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 21:31 UTC |
David GlennChief Financial Officer
|
SaleCommon Stock | 4,440 | $120.02 | $532,888.80 |
DisclosureSEC source: 0001555280-19-000288 · wf-form4_157549504654554.xml · nonDerivative · entry 2 David Glenn · CIK 0001606256 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,288 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 21:31 UTC |
David GlennChief Financial Officer
|
Exercise / conversionCommon Stock | 4,440 | $51.23 | $227,461.20 |
DisclosureSEC source: 0001555280-19-000288 · wf-form4_157549504654554.xml · nonDerivative · entry 1 David Glenn · CIK 0001606256 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2019 Filed Dec 2, 2019 21:25 UTC |
Knupp Catherine A.Executive Vice President
|
Exercise / conversionStock Option · Derivative | 28,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000286 · wf-form4_157532193497521.xml · derivative · entry 4 Knupp Catherine A. · CIK 0001567826 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,937 Underlying: Common Stock · 28,563 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; and 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option. Read SEC document |
| November 27, 2019 Filed Dec 2, 2019 21:25 UTC |
Knupp Catherine A.Executive Vice President
|
SaleCommon Stock | 4,101 | $122.17 | $501,019.17 |
DisclosureSEC source: 0001555280-19-000286 · wf-form4_157532193497521.xml · nonDerivative · entry 3 Knupp Catherine A. · CIK 0001567826 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,053 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.04 to $122.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 27, 2019 Filed Dec 2, 2019 21:25 UTC |
Knupp Catherine A.Executive Vice President
|
SaleCommon Stock | 24,462 | $121.24 | $2,965,772.88 |
DisclosureSEC source: 0001555280-19-000286 · wf-form4_157532193497521.xml · nonDerivative · entry 2 Knupp Catherine A. · CIK 0001567826 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,154 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.98 to $121.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 27, 2019 Filed Dec 2, 2019 21:25 UTC |
Knupp Catherine A.Executive Vice President
|
Exercise / conversionCommon Stock | 28,563 | $46.09 | $1,316,468.67 |
DisclosureSEC source: 0001555280-19-000286 · wf-form4_157532193497521.xml · nonDerivative · entry 1 Knupp Catherine A. · CIK 0001567826 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,616 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 17:20 UTC |
Fenton AndrewExecutive Vice President
|
SaleCommon Stock | 12,705 | $120.30 | $1,528,411.50 |
DisclosureSEC source: 0001555280-19-000284 · wf-form4_157472041543772.xml · nonDerivative · entry 1 Fenton Andrew · CIK 0001538226 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,530 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.99 to $120.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 22:07 UTC |
Chen Heidi C.Executive Vice President
|
Exercise / conversionStock Option · Derivative | 11,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000282 · wf-form4_157471960595105.xml · derivative · entry 3 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,587 Underlying: Common Stock · 11,425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The option vests on the third anniversary of the date of grant. F3 · derivative.exercise_price: 11,425 options granted February 27, 2015 at an exercise price of $46.09 per option. F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F6 · balance_after: 28,299 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; and 14,921 options granted February 12, 2019 at an exercise price of $87.51 per option. Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 22:07 UTC |
Chen Heidi C.Executive Vice President
|
SaleCommon Stock | 11,425 | $119.67 | $1,367,229.75 |
DisclosureSEC source: 0001555280-19-000282 · wf-form4_157471960595105.xml · nonDerivative · entry 2 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,463 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.51 to $119.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 22:07 UTC |
Chen Heidi C.Executive Vice President
|
Exercise / conversionCommon Stock | 11,425 | $46.09 | $526,578.25 |
DisclosureSEC source: 0001555280-19-000282 · wf-form4_157471960595105.xml · nonDerivative · entry 1 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2019 Filed Nov 20, 2019 21:46 UTC |
Alaix Juan RamonDirector · Chief Executive Officer
|
Exercise / conversionStock Option · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000280 · wf-form4_157428637962190.xml · derivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 711,046 Underlying: Common Stock · 50,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F3 · derivative.exercise_price: 50,000 options granted February 27, 2015 at an exercise price of $46.09 per option. F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F6 · balance_after: 109,954 options granted February 27, 2015 at an exercise price of $46.09 per option; 187,667 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option; and 110,192 options granted February 12, 2019 at an exercise price of $87.51 per option. Read SEC document |
| November 19, 2019 Filed Nov 20, 2019 21:46 UTC |
Alaix Juan RamonDirector · Chief Executive Officer
|
SaleCommon Stock | 50,000 | $119.13 | $5,956,500.00 |
DisclosureSEC source: 0001555280-19-000280 · wf-form4_157428637962190.xml · nonDerivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,013 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.80 to $119.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2019 Filed Nov 20, 2019 21:46 UTC |
Alaix Juan RamonDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 50,000 | $46.09 | $2,304,500.00 |
DisclosureSEC source: 0001555280-19-000280 · wf-form4_157428637962190.xml · nonDerivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2019 Filed Nov 20, 2019 21:30 UTC |
Lagano RoxanneExecutive Vice President
|
Exercise / conversionStock Option · Derivative | 4,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000278 · wf-form4_157428536698629.xml · derivative · entry 3 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,786 Underlying: Common Stock · 4,463 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 4,463 options granted February 27, 2015 at an exercise price of $46.09 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 8,926 options granted February 27, 2015 at an exercise price of $46.09 per option; 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; and 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option. Read SEC document |
| November 19, 2019 Filed Nov 20, 2019 21:30 UTC |
Lagano RoxanneExecutive Vice President
|
SaleCommon Stock | 4,463 | $118.99 | $531,052.37 |
DisclosureSEC source: 0001555280-19-000278 · wf-form4_157428536698629.xml · nonDerivative · entry 2 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,727 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.58 to $119.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2019 Filed Nov 20, 2019 21:30 UTC |
Lagano RoxanneExecutive Vice President
|
Exercise / conversionCommon Stock | 4,463 | $46.09 | $205,699.67 |
DisclosureSEC source: 0001555280-19-000278 · wf-form4_157428536698629.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2019. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 21:16 UTC |
Chen Heidi C.Executive Vice President
|
Exercise / conversionStock Option · Derivative | 11,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000276 · wf-form4_157428455282199.xml · derivative · entry 3 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,012 Underlying: Common Stock · 11,425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The option vests on the third anniversary of the date of grant. F3 · derivative.exercise_price: 11,425 options granted February 27, 2015 at an exercise price of $46.09 per option. F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F6 · balance_after: 11,425 options granted February 27, 2015 at an exercise price of $46.09 per option; 28,299 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; and 14,921 options granted February 12, 2019 at an exercise price of $87.51 per option. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 21:16 UTC |
Chen Heidi C.Executive Vice President
|
SaleCommon Stock | 11,425 | $118.86 | $1,357,975.50 |
DisclosureSEC source: 0001555280-19-000276 · wf-form4_157428455282199.xml · nonDerivative · entry 2 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,463 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.75 to $118.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 21:16 UTC |
Chen Heidi C.Executive Vice President
|
Exercise / conversionCommon Stock | 11,425 | $46.09 | $526,578.25 |
DisclosureSEC source: 0001555280-19-000276 · wf-form4_157428455282199.xml · nonDerivative · entry 1 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 21:13 UTC |
Lewis Clinton A. Jr.Executive Vice President
|
Exercise / conversionStock Option · Derivative | 3,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000274 · wf-form4_157385240338622.xml · derivative · entry 3 Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,628 Underlying: Common Stock · 3,566 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. Each option vests on the third anniversary of the date of grant. F4 · derivative.exercise_price: 3,566 options granted January 31, 2013 at an exercise price of $26.00 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 3,566 options granted January 31, 2013 at an exercise price of $26.00 per option; 46,816 options granted March 4, 2014 at an exercise price of $30.89 per option; 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option; 35,746 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; and 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 21:13 UTC |
Lewis Clinton A. Jr.Executive Vice President
|
SaleCommon Stock | 6,123 | $116.13 | $711,063.99 |
DisclosureSEC source: 0001555280-19-000274 · wf-form4_157385240338622.xml · nonDerivative · entry 2 Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,461 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.70 to $116.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 21:13 UTC |
Lewis Clinton A. Jr.Executive Vice President
|
Exercise / conversionCommon Stock | 3,566 | $26.00 | $92,716.00 |
DisclosureSEC source: 0001555280-19-000274 · wf-form4_157385240338622.xml · nonDerivative · entry 1 Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2018. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 22:17 UTC |
PECK KRISTIN CDirector · Executive Vice President
|
Exercise / conversionStock Option · Derivative | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000272 · wf-form4_157376981327822.xml · derivative · entry 4 PECK KRISTIN C · CIK 0001488267 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,319 Underlying: Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. Each option vests on the third anniversary of the date of grant. F5 · derivative.exercise_price: 7,500 options granted January 31, 2013 at an exercise price of $26.00 per option. F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F8 · balance_after: 10,385 options granted January 31, 2013 at an exercise price of $26.00 per option; 78,651 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; and 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 22:17 UTC |
PECK KRISTIN CDirector · Executive Vice President
|
SaleCommon Stock | 466 | $117.74 | $54,866.84 |
DisclosureSEC source: 0001555280-19-000272 · wf-form4_157376981327822.xml · nonDerivative · entry 3 PECK KRISTIN C · CIK 0001488267 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,377 F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.68 to $117.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 22:17 UTC |
PECK KRISTIN CDirector · Executive Vice President
|
SaleCommon Stock | 11,034 | $117.14 | $1,292,522.76 |
DisclosureSEC source: 0001555280-19-000272 · wf-form4_157376981327822.xml · nonDerivative · entry 2 PECK KRISTIN C · CIK 0001488267 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,843 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.67 to $117.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 22:17 UTC |
PECK KRISTIN CDirector · Executive Vice President
|
Exercise / conversionCommon Stock | 7,500 | $26.00 | $195,000.00 |
DisclosureSEC source: 0001555280-19-000272 · wf-form4_157376981327822.xml · nonDerivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,877 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2018. Read SEC document |
| October 14, 2019 Filed Oct 16, 2019 20:20 UTC |
Lewis Clinton A. Jr.Executive Vice President
|
Exercise / conversionStock Option · Derivative | 3,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000261 · wf-form4_157125719113424.xml · derivative · entry 3 Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,194 Underlying: Common Stock · 3,566 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. Each option vests on the third anniversary of the date of grant. F4 · derivative.exercise_price: 3,566 options granted January 31, 2013 at an exercise price of $26.00 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 7,132 options granted January 31, 2013 at an exercise price of $26.00 per option; 46,816 options granted March 4, 2014 at an exercise price of $30.89 per option; 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option; 35,746 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; and 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option. Read SEC document |
| October 14, 2019 Filed Oct 16, 2019 20:20 UTC |
Lewis Clinton A. Jr.Executive Vice President
|
SaleCommon Stock | 6,123 | $128.62 | $787,540.26 |
DisclosureSEC source: 0001555280-19-000261 · wf-form4_157125719113424.xml · nonDerivative · entry 2 Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,018 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.60 to $128.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 14, 2019 Filed Oct 16, 2019 20:20 UTC |
Lewis Clinton A. Jr.Executive Vice President
|
Exercise / conversionCommon Stock | 3,566 | $26.00 | $92,716.00 |
DisclosureSEC source: 0001555280-19-000261 · wf-form4_157125719113424.xml · nonDerivative · entry 1 Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,141 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.